Fidelity Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-19
| Closed | – | – | 4182 |
|
|
2020
Q2 | $0 | Sell |
19
-511,504
| -100% | -$7.12M | ﹤0.01% | 4420 |
|
|
2020
Q1 | $3.65M | Sell |
511,523
-303,914
| -37% | -$3.79M | ﹤0.01% | 2028 |
|
|
2019
Q4 | $19.5M | Buy |
815,437
+79,710
| +11% | +$2.2M | ﹤0.01% | 1604 |
|
|
2019
Q3 | $19.7M | Buy |
735,727
+214,097
| +41% | +$6.01M | ﹤0.01% | 1577 |
|
|
2019
Q2 | $14.2M | Sell |
521,630
-484,990
| -48% | -$15.2M | ﹤0.01% | 1758 |
|
|
2019
Q1 | $34.9M | Sell |
1,006,620
-952
| -0.1% | -$27.5K | ﹤0.01% | 1371 |
|
|
2018
Q4 | $19.7M | Sell |
1,007,572
-616,914
| -38% | -$12.7M | ﹤0.01% | 1556 |
|
|
2018
Q3 | $43.3M | Sell |
1,624,486
-376,931
| -19% | -$12.3M | ﹤0.01% | 1336 |
|
|
2018
Q2 | $75.6M | Sell |
2,001,417
-1,468
| -0.1% | -$56.2K | 0.01% | 1075 |
|
|
2018
Q1 | $65.4M | Sell |
2,002,885
-2,242,361
| -53% | -$98.4M | 0.01% | 1173 |
|
|
2017
Q4 | $207M | Sell |
4,245,246
-1,515,210
| -26% | -$76.6M | 0.02% | 684 |
|
|
2017
Q3 | $311M | Buy |
5,760,456
+1,971,673
| +52% | +$116M | 0.04% | 500 |
|
|
2017
Q2 | $213M | Sell |
3,788,783
-113,217
| -3% | -$4.53M | 0.03% | 664 |
|
|
2017
Q1 | $153M | Buy |
3,902,000
+205,751
| +6% | +$6.55M | 0.02% | 811 |
|
|
2016
Q4 | $82.9M | Sell |
3,696,249
-133,566
| -3% | -$2.61M | 0.01% | 1088 |
|
|
2016
Q3 | $87M | Sell |
3,829,815
-2,492,156
| -39% | -$58.5M | 0.01% | 1044 |
|
|
2016
Q2 | $149M | Sell |
6,321,971
-40,915
| -0.6% | -$1.01M | 0.02% | 791 |
|
|
2016
Q1 | $130M | Sell |
6,362,886
-566,400
| -8% | -$18M | 0.02% | 860 |
|
|
2015
Q4 | $357M | Buy |
6,929,286
+564,656
| +9% | +$27.4M | 0.05% | 420 |
|
|
2015
Q3 | $271M | Buy |
6,364,630
+134,200
| +2% | +$6.48M | 0.04% | 497 |
|
|
2015
Q2 | $284M | Buy |
6,230,430
+39,000
| +0.6% | +$1.57M | 0.04% | 521 |
|
|
2015
Q1 | $235M | Buy |
6,191,430
+422,100
| +7% | +$14.5M | 0.03% | 616 |
|
|
2014
Q4 | $163M | Buy |
5,769,330
+1,129,410
| +24% | +$31.4M | 0.02% | 772 |
|
|
2014
Q3 | $117M | Buy |
4,639,920
+349,970
| +8% | +$9.22M | 0.02% | 895 |
|
|
2014
Q2 | $125M | Buy |
4,289,950
+909,050
| +27% | +$22M | 0.02% | 877 |
|
|
2014
Q1 | $87.6M | Buy |
3,380,900
+1,624,900
| +93% | +$43.4M | 0.01% | 1048 |
|
|
2013
Q4 | $45.2M | Buy |
1,756,000
+768,500
| +78% | +$18.7M | 0.01% | 1365 |
|
|
2013
Q3 | $26.4M | Buy |
987,500
+342,900
| +53% | +$8.16M | ﹤0.01% | 1592 |
|
|
2013
Q2 | $15.8M | Buy |
+644,600
| New | +$12.8M | ﹤0.01% | 1749 |
|
Fidelity Investments's PTLA Position: Q3 2020 in Review
Fidelity Investments sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 19 shares.
Fidelity Investments first reported a position in PTLA in Q2 2013 and held it in 29 quarters. The position peaked at $357M in Q4 2015. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Fidelity Investments reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Fidelity Investments sold 19 Portola Pharmaceuticals, Inc. shares in Q3 2020.
- Fidelity Investments first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
- Fidelity Investments's Portola Pharmaceuticals, Inc. position peaked at $357M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Fidelity Investments's 13F filing for Q3 2020, filed 13 Nov 2020.